Citro-Mag Solution
Natural health product licensed in Canada
- Other names
- Citro-Mag (Cherry Flavour)
- Licence holder
- Teva Canada Limited
- NPN or DIN-HM
- 00262609
- Status
- Active licence
- Licence date
- 28 November 2007
- Revision date
- 30 June 2022
- Form
- Solution
- Route of administration
- Orale
- Application type
- DIN de transition
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
solution de sorbitol à 70 %, Eau purifiée, Citrus limon, Natural and artificial cherry flavour, Benzoate de sodium, Bicarbonate de sodium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Enfants | Not specified | Not specified | Not specified |
| Adultes | Not specified | 300 mL | Not specified |
| Adultes | Not specified | minimum: 75 mL ; maximum: 150 mL | Not specified |
Uses authorised in Canada
Text supplied in English because no French text is available.
Laxative and purgative.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Use only as directed. Do not use in the presence of undiagnosed abdominal pain, nausea or vomiting. Rectal bleeding or failure to respond may indicate a serious condition. Consult a physician. Persons on a low sodium diet or who have impaired renal function should avoid use of this product unless directed by a physician. Use of this product may result in abdominal cramping or nausea. Repeated or prolonged use may result in habituation or dependence on laxatives or bodily function. Do not take any type of laxative for more than one (1) week, unless your physician has ordered a special schedule for you. A laxative should not be taken within two (2) hours of another medication because the desired effects of the other medicine may be reduced. This preparation should only be used as a purgative upon the recommendation of a physician when preparing the patient for a medical procedure necessitating a clear colon. Keep out of reach of children.
Source
Official Health Canada record, licence 00262609
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2022. Photograph the packaging to check whether it has changed. Photograph the packaging